A targeted NGS platform developed for the comprehensive detection and characterization of bacterial and fungal pathogens, viral agents (HSV/HPV), and sexually transmitted infections (STIs), alongside the molecular profiling of antimicrobial resistance (AMR) markers for clinical diagnostics in vaginal and uterine specimens – Coming in Q2 2026.